All Resources
Our resource hub to discover reports, policy papers and other forms of informative content
Developing a Pan-Canadian Genomics Strategy: Innovative Medicines Canada Response
IMC supports the creation of a Pan Canadian Genomics Strategy (PCGS) to help Canada advance its international leadership and increase capacity in genomics through commercialization and adoption….
Bluesky Project
Reimagining Canada’s Approval and Reimbursement System for Innovative Medicines February 2022…
2022 Code of Ethical Practices
…activities of all our members’ employees as they interact with stakeholders to commercialize prescription medicines (excluding medical devices and over-the-counter products). Adherence to the Code is a condition of membership.…
Statistics Canada: The Canadian Research and Development Pharmaceutical Sector 2018
Statistic’s Canada outlines the economic impact of the Canadian research and development pharmaceutical sector….
Research Note: Oncology Clinical Trials: Canada Within the International Context
Clinical trials provide Canadian oncology patients with earlier access to new, innovative cancer treatments. But changes pending to the PMPRB will make the Canadian pharmaceutical market less attractive for investment….
